Follow the 爱尔眼科 stock price and the full insider trade history of the company, a publicly traded company based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 爱尔眼科 has recorded 49 public disclosures. Market capitalisation: €102.4bn. The latest transaction was filed on 15 July 2022 (Purchase). Among the most active insiders: 吴士君. The full history is accessible without an account.
49
Insider Decl.
0
Thresholds
·
49 ops.
Buy Volume
·
0 ops.
Sell Volume
33Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 6,418 of 25,804 companies
64.3
score / 100
Value
56
Quality
73
FCF yld5.0%
Earn yld4.2%
EV/EBITDA13.0x
ROE15%
Gross mgn47%
Net mgn14%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
